Abstract
Recent publications have suggested that African medicinal plants and their derived products could be viable source of new and better trypanocidal drugs. Nowadays, in silico methods are often used in drug discovery processes to identify new potential drug leads. In this study, we have developed a small library named Afrotryp, comprising three-dimensional chemical structures of potential trypanocidal compounds derived from medicinal plants in Africa (a total of 321 unique chemical structures). We have predicted the pharmacokinetic properties of the library using Qikprop software and employed the three docking/scoring methods implemented in Molecular Operating Environment Dock Tool to assess the affinity of the library dataset towards the binding site of six selected validated anti-Trypanosoma drug targets. It was observed that about 42% of the compounds contained in the Afrotryp dataset were predicted to show a good overall performance in terms of predicted parameters for absorption, distribution, metabolism, elimination and toxicity properties. Docking calculations identified 15 compounds with lowest theoretical binding energies toward the studied proteins, nine of which are suited for the treatment of stage 2 human African trypanosomiasis, due to their low polar surface area. Analysis of their binding modes gave basis for the observed unique molecular interactions which exist between the Afrotryp dataset and the six studied drug targets. The results lay the foundations for the rational development of novel trypanocidal drugs with improved potency.










Similar content being viewed by others
References
Amaechi N (2001) Toxicity of antiprotozoan drug diminazeneaceturate in rats. J Sustain Agric Environ 3:365–370
Andriani G, Amata E, Beatty J, Clements Z, Coffey BJ, Courtemanche G, Devine W, Erath J, Juda CE, Wawozak Z, Wood JT, Lepesheva GI, Rodriguez A, Pollastri MP (2013) Antitrpanosomal lead discovery: identification of a ligand-efficient inhibitor of Trypanosomacruzi CYP51 and parasite growth. J Med Chem 56:2556–2567
Aronov AM (2005) Predictive in silico modeling for hERG channel blockers. Drug Discov Today 10:149–155
Artursson P (1990) Epithelial transport of drug in cell culture I: a model for studying the passive diffusion of drugs over intestinal absortive (Caco-2) cells. J Pharm Sci 79(6):476–482
Artursson P, Karlsson J (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Rec Commun 175(3):880–885
Awulu EA, Oniye SJ, Adelanwa MA (2013) Phytochemical screening and in vivo antitrypanosomal activity of methanol extracts of Peristrophe bicalyculata in mice infected with Trypanosoma evansi. Int J Sci Technol 3:34–39
Bakker BM, Michelsi PAM, Opperdoesi FR, Hans V, Westerhoff HV (1999) Metabolic control analysis of glycolysis in trypanosomes as an approach to improve selectivity and effectiveness of drugs. J Biol Chem 274:14551–14559
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28:235–342
Cavalli A, Poluzzi E, De Ponti F, Recanatini M (2002) Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K+ channel blockers. J Med Chem 45:3844–3853
Chemical Computing Group (2010) Molecular Operating Envrinment (MOE) software
Colmenarejo G, Alvarez-Pedraglio A, Lavandera JL (2001) Cheminformatic models to predict binding affinities to human serum albumin. J Med Chem 44:4370–4378
D’Archivio S, Medina M, Cosson A, Chamond N, Rotureau B, Minoprio P (2011) Genetic engineering of Trypanosoma (Dutonella) vivaxandin vitro differentiation under axenic conditions. PloS Negl Trop Dis 5:e1461
Demir O, Ladaied M, Merritt C, Stuart K, Amaro RE (2014) Computer-aided discovery of trypanosomabrucei RNA-editing terminal uridylyltransferase 2 inhibitors. Chem Biol Drug Des 84(2):131–139
Deng J, Ernst NL, Turley S, Stuart KD, Hol WG (2005) Structural basis for UTP specificity of RNA editing TUTases from trypanosomabrucei. Embo J 24:4007–4017
Deng W, Jiang X, Mei Y, Sun J, Ma R, Liu X, Sun H, Tian H, Sun X (2008) Role of ornithine decarboxylase in breast cancer. Acta Biochem Biophys Sin 40:235–243
DesJarlais RL, Sheridan RP, Seibel GL, Dixon JS, Kuntz ID, Venkataraghavan R (1988) Using shape complementary as an initial screen in designing ligands for a receptor binding site of known 3D structure. J Med Chem 31:722–729
Dictionary of natural products on CD-rom (2005) Chapman and Hall/CRC Press, London
Duffy EM, Jorgensen WL (2000) Prediction of properties from simulations: free energies of solvation in hexadecane, octanol, andwater. J Am Chem Soc 122:2878–2888
Edelsbrunner H (2007) Weighted alpha shapes. Department of Computer Science, University of Illinois at Urbana-Champaign, Urbana, IL
Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular PSA as a sum of fragment based contributions and its application to the prediction of drug transport properties. J Med Chem 43:3714–3717
Fan Y, Shi LM, Kohn KW, Pommier Y, Weinstein JN (2001) Quantitative structure-antitumoractivity relationships of camptothecin analogues: cluster analysis and genetic algorithmbasedstudies. J Med Chem 44:3254–3263
Feher M, Schmidt JM (2003) Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci 43(1):218–227
Ghose AK, Herbertz T, Hudkins RL, Dorsey BD, Mallamo JP (2012) Knowledge-based central nervous system (CNS) lead selection and lead optimization for CNS drug discovery. Neuroscience 3:50–68
Ghose AK, Viswanadhan VN, Wendoloski JJ (1999) A knowledge based approach in designing combinatorial or medicinal chemistry libraries for drug discovery 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1(1):55–68
Grishin NV, Osterman AL, Brooks HB, Phillips MA, Goldsmith EJ (1999) X-ray structure of ornithine decarboxylase from Trypanosoma brucei: the native structure and the structure in complex with alpha-difluoromethylornithine. Biochemistry 38:15174–15184
Halgren TA (1996) Merck molecular forcefield. J Comput Chem 17:490–641
Hoet S, Opperdoes F, Brun R, Quetin-Leclercq J (2004) Natural products active against African trypanosomes: a step towards new drugs. Nat Prod Rep 21:353–364
Ibrahim MA, Mohammed A, Isah MB, Aliyu AB (2014) Anti-trypanosomal activity of African medicinal plants: a review update. J Ethnopharmacol 154:26–54
Irvine JD, Takahashi L, Lockhart K, Cheong J, Tolan JW, Selick HE, Grove JR (1999) MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening. J Pharm Sci 88:28–33
Jorgensen WL, Duffy EM (2000) Prediction of drug solubility from Monte Carlo simulations. Bioorg Med Chem Lett 10:1155–1158
Jorgensen WL, Duffy EM (2002) Prediction of drug solubility fromstructure. Adv Drug Deliv Rev 54:355–366
Kaiser M, Bray MA, Cal M, Trunz BB, Torreele E, Brun R (2011) Antitrypanosomal activity of Fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness. Antimicrob Agents Chemother 55:5602–5608
Kirchhoff LV (2000) Agents of African Trypanosomiasis (Sleeping Sickness). In: Mandell GL, Benett JE and Dolin R (ed) Mandell, Douglas, and Benett’s principles and practice of infectious diseases, Churchill Livingstone, Philadelphia, PA, pp 2853–2858
Koehn FE, Carter GT (2005) The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4:206–220
Kuettel S, Greenwald J, Kostrewa D, Ahmed S, Scapozza L, Perozzo R (2011) Crystal structures of T.b. rhodesiense adenosine kinase complexed with inhibitor and activator: Implications for catalysis and hyperactivation. PloS Negl Trop Dis 5:E1164
Kuettel S, Mosimann M, Maser P, Kaiser M, Brun R, Scapozza L, Perozzo R (2009) Adenosine kinase of T. b. Rhodesiense identified as the putative target of 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine using chemical proteomics. PloS Negl Trop Dis 3(8):e506
Lepesheva GI, Zaitseva NG, Nes WD, Zhou W, Arase M, Liu J, Hill GC, Waterman MR (2006) CYP51 from Trypanosomacruzi: a phyla-specific residue in the β’ helix defines substrate s preferences of Sterol 14α-demethylase. J Biol Chem 281:3577–3585
Linares GEG, Ravaschino EL, Rodriguez JB (2006) Progresses in the field of drug design to combat tropical protozoan parasitic diseases. Curr Med Chem 13:335–360
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3–25
Luco JM (1999) Prediction of brain–blood distribution of a large set of drugs from structurally derived descriptors using partial least squares (PLS) modelling. J Chem Inf Comput Sci 39:396–404
Mangal M, Sagar P, Singh H, Raghava GPS, Agarwal SM (2013) NPACT: Naturally occurring plant-based anti-cancer compound activity-target database. Nucleic Acids Res 41:D1124–D1129
Mao J, Mukherjee S, Zhang Y, Cao R, Sanders JM, Song Y, Zhang Y, Meints GA, Gao YG, Mukkamala D, Hudock MP, Oldfield E (2006) Solid-state NMR, crystallographic, and computational investigation of bisphosphonates and farnesyldiphosphate synthase-bisphosphate complexes. J Am ChemSoc 128:14485–14497
Maser P, Luscher A, Kaminsky R (2003) Drug transport and drug resistance in African trypanosomes. Drug Resist Updat 6:281–290
Meyer AY (1986) Molecular mechanics and molecular shape. III Surface area and cross-sectional areas of organic molecules. J Comput Chem 7:144–152
Chemical Computing Group Inc. (2010) Molecular Operating Environment version 2010: Montreal, Canada
Montalvetti A, Fernandez A, Sanders JM, Ghosh S, Van Brussel E, Oldfield E, Docampo R (2003) Farnesyl pyrophosphate synthase is an essential enzyme in Trypanosoma brucei, in vitro RNA interference and in vivo inhibition studies. J Biol Chem 278:17075–17083
Myrdal PB, Yalkowsky SH (2007) Solubilization of drugs in aqueous media. In: Swarbrick J (Ed) Encyclopedia of pharmaceutical technology. Informa Health Care, New York, NY
Noble ME, Verlinde CL, Groendijk H, Kalk KH, Wierenga RK, Hol WG (1991) Crystallographic and molecular modeling studies on trypanosomal triosephosphateisomerase: Critical assessment of the predicted and observed structures of the complex with 2-phosphoglycerate. J Med Chem 34:2709–2718
Ntie-Kang F, Nwodo NJ, Ibezim A, Simoben CV, Karaman B, Ngwa FV, Sippl W, Adikwu MU, Mbaze LM (2014) Molecular modeling of potential anticancer agents from African medicinal plants. J Chem Inf Model 54:2433–2450
Ntie-Kang F, Lifongo LL, Judson NP, Sippl W, Efange SMN (2014) How “drug-like” are naturally occurring anti-cancer compounds? J Mol Model 20:1–13
Ntie-Kang F, Lifongo LL, Mbah JA, Owono LCO, Megnassan E, Mbaze LM, Judson PN, Sippl W, Efange SMN (2013a) In silico drug metabolism and pharmacokinetic profiles of natural products from medicinal plants in the Congo basin. In Silico Pharmacol 1:12
Ntie-Kang F, Mbah JA, Lifongo LL, OwonoOwono LC, Megnassan E, Mbaze LM, Judson PN, Sippl W, Efange SMN (2013c) Assessing the pharmacokinetic profile of the CamMedNP natural products database: an in silico approach. Org Med Chem Lett 3:10
Ntie-Kang F, Zofou D, Babiaka SB, Meudom R, Scharfe M, Lifongo LL, Mbah JA, Mbaze LM, Sippl W, Efange SMN (2013b) AfroDb: a select highly potent and diverse natural product library from African medicinal plants. PLoS One 8(10):e78085
Nwodo NJ, Ibezim A, Ntie-Kang F, Adikwu MU, Mbah CJ (2015) Anti-trypanosomal activity of Nigerian plants and their constituents. Molecules 20:7750–7771
Olivares-Illana V, Pérez-Montfort R, López-Calahorra F, Costas M, Rodríguez-Romero A, Tuena de Gómez-Puyou MT, Gómez Puyou A (2006) Structural differences in triosephosphateisomerase from different species and discovery of a multitrypanosomatid inhibitor. Biochemistry 45:2556–2560
Oprea TI (2002) Current trends in lead discovery: are we looking for the appropriate properties? J Comput Aided Mol Des 16:325–334
Palm K, Stenbery P, Luthman K, Artursson P (1997) Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm Res 14:154–571
Paul J, Gnanam R, Jayadeepa RM, Arul L (2013) Anti-cancer activity on Graviola, an excitingmedicinal plant extract vs various cancer cell lines and a detailed computational study onits potent anti-cancerous leads. Curr Top Med Chem 13:1666–1673
Pegg AE (1988) Polyamine metabolism and its importance in neoplastic growth and a target for chemopreventive. Cancer Res 48:759–774
Potts RO, Guy RH (1995) A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm Res 12:1628–1633
Quinn RJ, Carroll AR, Pham NB, Baron P, Palframan ME, Suraweera L, Pierens GK, Muresan S (2008) Developing a drug-like natural product library. J Nat Prod 71:464–468
Schneider G (2002) Trends in virtual computational library design. Curr Med Chem 9:2095–2102
Schrödinger Press (2011) QikProp 3.4 user manual. LLC, New York, NY
Sterling T, Irwin JJ (2015) ZINC 15 – ligand discovery for everyone. J Chem Inf Model 55:2324–2337
Teague SJ, Davis AM, Leeson PD, Opea TI (1999) The design of leadlike combinatorial libraries. Angew Chem Int Ed 38:3743–3748
Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615–2623
Vemula VR, Lagishetty V, Lingala S (2010) Solubility enhancement techniques. Intl J Pharm Sci Rev Res 5(1):41–51
Vyas VK, Ghate M, Goel A (2013) Pharmacophore modeling, virtual screening, docking and insilico ADMET analysis of protein Kinase B (PKB β) inhibitors. J Mol Graph Model 42:17–25
Walters PW, Stahl MT, Murck MA (1996) Virtual screening – an overview. Res Focus 3(4):160–178
WHO Media Centre (2016) Trypanosomiasis, human African (sleeping sickness). https://www.who.int/mediacentre/factsheets/fs259/en. Accessed 31 May 2016
Acknowledgements
The authors thank Chemical and Bioactivity Information Centre, Cameroon for access to the natural products database and technical support. FNK currently holds a Georg Forster fellowship for postdoctoral researchers, obtained from the Alexander von Humboldt Foundation, Germany.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing financial interests
The authors declare no competing financial interests.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Ibezim, A., Debnath, B., Ntie-Kang, F. et al. Binding of anti-Trypanosoma natural products from African flora against selected drug targets: a docking study. Med Chem Res 26, 562–579 (2017). https://doi.org/10.1007/s00044-016-1764-y
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1007/s00044-016-1764-y


